What has changed recently / 2026-09-09
The United States expanded an accelerated approval in HER2-mutated lung cancer
This is a product-, mutation-, disease-stage- and region-specific regulatory change, not proof of approval in China or suitability for an individual.
Read the original sources
This information does not replace medical diagnosis, treatment or prescribing, and it cannot predict an individual's lifespan.